Relapsing-Remitting Multiple Sclerosis

GPTKB entity

Statements (51)
Predicate Object
gptkbp:instanceOf Multiple Sclerosis subtype
gptkbp:abbreviation gptkb:RRMS
gptkbp:affects gptkb:spinal_cord
brain
gptkbp:associatedWith central nervous system
demyelination
gptkbp:cause autoimmune response
gptkbp:characterizedBy episodes of neurological symptoms
periods of remission
gptkbp:complication gptkb:depression
spasticity
cognitive impairment
disability progression
gptkbp:diagnosedBy neurological examination
MRI
lumbar puncture
gptkbp:differentialDiagnosis gptkb:systemic_lupus_erythematosus
gptkb:neuromyelitis_optica
sarcoidosis
acute disseminated encephalomyelitis
gptkbp:diseaseCourse relapses followed by recovery
gptkbp:field neurology
gptkbp:firstDescribed 1868
gptkbp:gender more common in women
https://www.w3.org/2000/01/rdf-schema#label Relapsing-Remitting Multiple Sclerosis
gptkbp:ICD-10_code G35
gptkbp:onset 20-40 years
gptkbp:percentageOfMSCases about 85%
gptkbp:prevalence most common form of MS
gptkbp:prognosis variable
gptkbp:progression may convert to Secondary Progressive MS
gptkbp:relatedTo gptkb:Primary_Progressive_Multiple_Sclerosis
Progressive-Relapsing Multiple Sclerosis
Secondary Progressive Multiple Sclerosis
gptkbp:riskFactor gptkb:Epstein-Barr_virus_infection
smoking
genetic predisposition
vitamin D deficiency
gptkbp:subspecies gptkb:Multiple_Sclerosis
gptkbp:symptom fatigue
muscle weakness
bladder dysfunction
difficulty with coordination
numbness
vision problems
gptkbp:treatment disease-modifying therapies
physical therapy
corticosteroids
gptkbp:分布地区 more common in northern latitudes
gptkbp:bfsParent gptkb:RRMS
gptkbp:bfsLayer 7